Tamoxifen is a non-steroidal antiestrogen used to treat estrogen receptor positive breast cancers as well as prevent the incidence of breast cancer in high risk populations. Tamoxifen is used alone or as an adjuvant in these treatments. Tamoxifen may no longer be the preferred treatment for these types of cancers as patients generally have better survival, s...
Tamoxifen is indicated to treat estrogen receptor positive metastatic breast cancer in adults, as an adjuvant in the treatment of early stage estrogen receptor positive breast cancer in adults, to reduce the risk of invasive breast cancer after surgery and radiation in adult women with ductal carcinoma in situ.
Department of Surgery, Medical College, Kolkata, Kolkata, West Bengal, India
Korea University Anam Hopital, Seoul, Korea, Republic of
CHU de Toulouse Rangueil, Toulouse, France
Institut Claudius Regaud, Toulouse, France
Department of Surgery, Korea Cancer Center Hospital, Seoul, Korea, Republic of
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Tata Memorial Center, Parel, Mumbai, India
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.